Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection

Frontiers in Immunology

Volumn 3, Issue JUL, 2012, Pages

  Seifert, Martina ^a   Stolk, Meaghan ^a   Polenz, Dietrich ^a   Volk, Hans Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute rejection; Humoral response; Inflammation; Kidney transplantation; Mesenchymal stromal cell

Indexed keywords

EID: 84872164299     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00202     Document Type: Article

References (52)

1. Audard, V., Matignon, M., Dahan, K., Lang, P., and Grimbert, P. (2008). Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview. Transpl. Int. 21, 11-17.
2. Barnett, N., Dorling, A., and Mamode, N. (2011). B cells in renal transplantation: pathological aspects and therapeutic interventions. Nephrol. Dial. Transplant. 26, 767-774.
3. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42-48.
4. Bruno, S., Grange, C., Deregibus, M. C., Calogero, R. A., Saviozzi, S., Collino, F., Morando, L., Busca, A., Falda, M., Bussolati, B., Tetta, C., and Camussi, G. (2009). Mesenchymal stem cellderived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20, 1053-1067.
5. Bussolati, B., and Camussi, G. (2006). Adult stem cells and renal repair. J. Nephrol. 19, 706-709.
6. Bussolati, B., Moggio, A., Collino, F., Aghemo, G., D'Armento, G., Grange, C., and Camussi, G. (2012). Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am. J. Physiol. Renal Physiol. 302, F116-F128.
7. Cao, H., Qian, H., Xu, W., Zhu, W., Zhang, X., Chen, Y., Wang, M., Yan, Y., and Xie, Y. (2010). Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusioninduced acute renal failure in rats. Biotechnol. Lett. 32, 725-732.
8. Casiraghi, F., Azzollini, N., Todeschini, M., Cavinato, R. A., Cassis, P., Solini, S., Rota, C., Morigi, M., Introna, M., Maranta, R., Perico, N., Remuzzi, G., and Noris, M. (2012). Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am. J. Transplant. doi: 10.1111/j.1600-6143.2012.04115.x [Epub ahead of print].
9. Caumartin, Y., Stephen, J., Deng, J. P., Lian, D., Lan, Z., Liu, W., Garcia, B., Jevnikar, A. M., Wang, H., Cepinskas, G., and Luke, P. P. (2011). Carbon monoxidereleasing molecules protect against ischemiareperfusion injury during kidney transplantation. Kidney Int. 79, 1080-1089.
10. Choi, S. J., Kim, J. K., and Hwang, S. D. (2010). Mesenchymal stem cell therapy for chronic renal failure. Expert Opin. Biol. Ther. 10, 1217-1226.
11. Crop, M. J., Korevaar, S. S., de Kuiper, R., Ijzermans, J. N., van Besouw, N. M., Baan, C. C., Weimar, W., and Hoogduijn, M. J. (2011). Human mesenchymal stem cells are susceptible to lysis by CD8+ T-cells and NK cells. Cell Transplant. doi: 10.3727/096368910X564076 [Epub ahead of print].
12. De Martino, M., Zonta, S., Rampino, T., Gregorini, M., Frassoni, F., Piotti, G., Bedino, G., Cobianchi, L., Dal Canton, A., Dionigi, P., and Alessiani, M. (2010). Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation. Transplant. Proc. 42, 1331-1335.
13. Donizetti-Oliveira, C., Semedo, P., Burgos-Silva, M., Cenedeze, M. A., Malheiros, D. M., Reis, M. A., Pacheco-Silva, A., and Camara, N. O. (2012). Adipose tissuederived stem cell treatment prevents renal disease progression. Cell Transplant. doi: 10.3727/096368911X623925 [Epub ahead of print].
14. Eggenhofer, E., Steinmann, J. F., Renner, P., Slowik, P., Piso, P., Geissler, E. K., Schlitt, H. J., Dahlke, M. H., and Popp, F. C. (2011). Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts. Transpl. Immunol. 24, 157-163.
15. Furuichi, K., Shintani, H., Sakai, Y., Ochiya, T., Matsushima, K., Kaneko, S., and Wada, T. (2012). Effects of adiposederived mesenchymal cells on ischemiareperfusion injury in kidney. Clin. Exp. Nephrol. doi: 10.1007/s10157-012-0614-6 [Epub ahead of print].
16. Gatti, S., Bruno, S., Deregibus, M. C., Sordi, A., Cantaluppi, V., Tetta, C., and Camussi, G. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemiareperfusioninduced acute and chronic kidney injury. Nephrol. Dial. Transplant. 26, 1474-1483.
17. Gong, W., Klopfel, M., Reutzel-Selke, A., Jurisch, A., Vogt, K., Haase, S., Hoflich, C., Polenz, D., Gerstmayer, B., Tomiuk, S., Volk, H. D., Pascher, A., and Sawitzki, B. (2009). High weight differences between donor and recipient affect early kidney graft function - a role for enhanced IL-6 signaling. Am. J. Transplant. 9, 1742-1751.
18. Griffin, M. D., Ritter, T., and Mahon, B. P. (2010). Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum. Gene Ther. 21, 1641- 1655.
19. Hara, Y., Stolk, M., Ringe, J., Dehne, T., Ladhoff, J., Kotsch, K., Reutzel-Selke, A., Reinke, P., Volk, H. D., and Seifert, M. (2011). In vivo effect of bone marrowderived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transpl. Int. 24, 1112-1123.
20. Harari-Steinberg, O., Pleniceanu, O., and Dekel, B. (2011). Selecting the optimal cell for kidney regeneration: fetal, adult or reprogrammed stem cells. Organogenesis 7, 123-134.
21. Hoogduijn, M. J., Roemelingvan Rhijn, M., Korevaar, S. S., Engela, A. U., Weimar, W., and Baan, C. C. (2011). Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies. Hum. Gene Ther. 22, 1587-1591.
22. Inoue, S., Popp, F. C., Koehl, G. E., Piso, P., Schlitt, H. J., Geissler, E. K., and Dahlke,M. H. (2006). Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81, 1589-1595.
23. Kotsch, K., Martins, P. N., Klemz, R., Janssen, U., Gerstmayer, B., Dernier, A., Reutzel-Selke, A., Kuckelkorn, U., Tullius, S. G., and Volk, H. D. (2007). Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. Antioxid. Redox Signal. 9, 2049-2063.
24. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., and Ringden, O. (2004). Treatment of severe acute graftversushost disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439- 1441.
25. Little, M. H. (2011). Renal organogenesis: what can it tell us about renal repair and regeneration? Organogenesis 7, 229-241.
26. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
27. Maitra, B., Szekely, E., Gjini, K., Laughlin, M. J., Dennis, J., Haynesworth, S. E., and Koc, O. N. (2004). Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33, 597-604.
28. Morigi, M., Benigni, A., Remuzzi, G., and Imberti, B. (2006). The regenerative potential of stem cells in acute renal failure. Cell Transplant. 15, S111-S117.
29. Morigi, M., Rota, C., Montemurro, T., Montelatici, E., Lo Cicero, V., Imberti, B., Abbate, M., Zoja, C., Cassis, P., Longaretti, L., Rebulla, P., Introna, M., Capelli, C., Benigni, A., Remuzzi, G., and Lazzari, L. (2010). Lifesparing effect of human cord bloodmesenchymal stem cells in experimental acute kidney injury. Stem Cells 28, 513-522.
30. Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G., Willemze, R., and Fibbe, W. E. (2006). Donorderived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108, 2114-2120.
31. Perico, N., Casiraghi, F., Introna, M., Gotti, E., Todeschini, M., Cavinato, R. A., Capelli, C., Rambaldi, A., Cassis, P., Rizzo, P., Cortinovis, M., Marasa, M., Golay, J., Noris, M., and Remuzzi, G. (2011). Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin. J. Am. Soc. Nephrol. 6, 412-422.
32. Popp, F. C., Eggenhofer, E., Renner, P., Geissler, E. K., Piso, P., Schlitt, H. J., and Dahlke,M.H.(2009). Mesenchymal stem cells can affect solid organ allograft survival. Transplantation 87, S57-S62.
33. Popp, F. C., Eggenhofer, E., Renner, P., Slowik, P., Lang, S. A., Kaspar, H., Geissler, E. K., Piso, P., Schlitt, H. J., and Dahlke, M. H. (2008). Mesenchymal stem cells can induce longterm acceptance of solid organ allografts in synergy with lowdose mycophenolate. Transpl. Immunol. 20, 55-60.
34. Ratajczak, M. Z. (2011). The emerging role of microvesicles in cellular therapies for organ/tissue regeneration. Nephrol. Dial. Transplant. 26, 1453-1456.
35. Roemelingvan Rhijn, M., Weimar, W., and Hoogduijn, M. J. (2012). Mesenchymal stem cells: application for solidorgan transplantation. Curr. Opin. Organ Transplant. 17, 55-62.
36. Sbano, P., Cuccia, A., Mazzanti, B., Urbani, S., Giusti, B., Lapini, I., Rossi, L., Abbate, R., Marseglia, G., Nannetti, G., Torricelli, F., Miracco, C., Bosi, A., Fimiani, M., and Saccardi, R. (2008). Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Arch. Dermatol. Res. 300, 115-124.
37. Schu, S., Nosov, M., O'Flynn, L., Shaw, G., Treacy, O., Barry, F., Murphy, M., O'Brien, T., and Ritter, T. (2011). Immunogenicity of allogeneic mesenchymal stem cells. J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2011.01509.x [Epub ahead of print]
38. Semedo, P., Wang, P. M., Andreucci, T. H., Cenedeze, M. A., Teixeira, V. P., Reis, M. A., Pacheco-Silva, A., and Camara, N. O. (2007). Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant. Proc. 39, 421-423.
39. Shi, C., Jia, T., Mendez-Ferrer, S., Hohl, T. M., Serbina, N. V., Lipuma, L., Leiner, I., Li, M. O., Frenette,P. S., and Pamer, E. G. (2011). Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating tolllike receptor ligands. Immunity 34, 590-601.
40. Singer, N. G., and Caplan, A. I. (2011). Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6, 457-478.
41. Stallone, G., Infante, B., and Gesualdo, L. (2010). Older donors and older recipients in kidney transplantation. J. Nephrol. 23, S98-S103.
42. Takemoto, S. K., Zeevi, A., Feng, S., Colvin, R. B., Jordan, S., Kobashigawa, J., Kupiec-Weglinski, J., Matas, A., Montgomery, R. A., Nickerson, P., Platt, J. L., Rabb, H., Thistlethwaite, R., Tyan, D., and Delmonico, F. L. (2004). National conference to assess antibodymediated rejection in solid organ transplantation. Am. J. Transplant. 4, 1033-1041.
43. Tan, J., Wu, W., Xu, X., Liao, L., Zheng, F., Messinger, S., Sun, X., Chen, J., Yang, S., Cai, J., Gao, X., Pileggi, A., and Ricordi, C. (2012). Induction therapy with autologous mesenchymal stem cells in livingrelated kidney transplants: a randomized controlled trial. JAMA 307, 1169-1177.
44. Tetta, C., Bruno, S., Fonsato, V., Deregibus, M. C., and Camussi, G. (2011). The role of microvesicles in tissue repair. Organogenesis 7, 105-115.
45. Tögel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., and Westenfelder, C. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiationindependent mechanisms. Am. J. Physiol. Renal Physiol. 289, F31-F42.
46. Tögel, F., Weiss, K., Yang, Y., Hu, Z., Zhang, P., and Westenfelder, C. (2007). Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal Physiol. 292, F1626-F1635.
47. Tögel, F., and Westenfelder, C. (2011). The role of multipotent marrow stromal cells (MSCs) in tissue regeneration. Organogenesis 7, 96-100.
48. van der Woude, F. J., Schnuelle, P., and Yard, B. A. (2004). Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury. J. Investig. Med. 52, 323-329.
49. Wise, A. F., and Ricardo, S. D. (2012). Mesenchymal stem cells in kidney inflammation and repair. Nephrology (Carlton) 17, 1-10.
50. Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R. G., Kobayashi, N., and Yarmush, M. L. (2010). Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 19, 667-679.
51. Yarmush, M. L. (2010). Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 19, 667-679.
52. Zhou, H. P., Yi, D. H., Yu, S. Q., Sun, G. C., Cui, Q., Zhu, H. L., Liu, J. C., Zhang, J. Z., and Wu, T. J. (2006). Administration of donorderived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant. Proc. 38, 3046-3051.